健康元(600380.SH)下属子公司获得药物临床试验批准通知书

智通财经2025-12-21

智通财经APP讯，健康元(600380.SH)发布公告，近日，公司控股子公司丽珠医药集团股份有限公司的控股子公司丽珠集团丽珠制药厂(简称：丽珠制药厂)收到国家药品监督管理局核准签发的关于NS-041片新增针对“治疗抑郁症”适应症的《药物临床试验批准通知书》(通知书编号：2025LP03436、2025LP03437)，同意NS-041片新增适应症开展临床试验。NS-041片是一款新型高选择性...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2593260501?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-21 15:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2593260501","market":"hk","top_or_hot":-1,"title":"健康元(600380.SH)下属子公司获得药物临床试验批准通知书","media":"智通财经","content":"<div>\n<p>智通财经APP讯，健康元(600380.SH)发布公告，近日，公司控股子公司丽珠医药集团股份有限公司的控股子公司丽珠集团丽珠制药厂(简称：丽珠制药厂)收到国家药品监督管理局核准签发的关于NS-041片新增针对“治疗抑郁症”适应症的《药物临床试验批准通知书》(通知书编号：2025LP03436、2025LP03437)，同意NS-041片新增适应症开展临床试验。NS-041片是一款新型高选择性...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1384094.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>健康元(600380.SH)下属子公司获得药物临床试验批准通知书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n健康元(600380.SH)下属子公司获得药物临床试验批准通知书\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-21 15:51 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1384094.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，健康元(600380.SH)发布公告，近日，公司控股子公司丽珠医药集团股份有限公司的控股子公司丽珠集团丽珠制药厂(简称：丽珠制药厂)收到国家药品监督管理局核准签发的关于NS-041片新增针对“治疗抑郁症”适应症的《药物临床试验批准通知书》(通知书编号：2025LP03436、2025LP03437)，同意NS-041片新增适应症开展临床试验。NS-041片是一款新型高选择性...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1384094.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0077","symbol_name":"质押式回购","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1384094.html","article_id":"2593260501","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2593260501","pubTimestamp":1766303472,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，健康元 发布公告，近日，公司控股子公司丽珠医药集团股份有限公司的控股子公司丽珠集团丽珠制药厂收到国家药品监督管理局核准签发的关于NS-041片新增针对“治疗抑郁症”适应症的《药物临床试验批准通知书》，同意NS-041片新增适应症开展临床试验。2023年12月27日，NS-041片获批开展“癫痫”适应症的临床试验，目前该适应症正在进行II期临床研究。本次NS-041片新增获批的临床试验适应症为“治疗抑郁症”。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600380":"健康元","BK0077":"质押式回购","BK0046":"生物疫苗","BK0028":"国家队","BK0239":"医药制造","BK0188":"融资融券","BK0114":"健康中国"},"translate_title":"A subsidiary of Joincare (600380. SH) obtained a drug clinical trial approval notice","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600380":1.5},"content_text":"智通财经APP讯，健康元(600380.SH)发布公告，近日，公司控股子公司丽珠医药集团股份有限公司的控股子公司丽珠集团丽珠制药厂(简称：丽珠制药厂)收到国家药品监督管理局核准签发的关于NS-041片新增针对“治疗抑郁症”适应症的《药物临床试验批准通知书》(通知书编号：2025LP03436、2025LP03437)，同意NS-041片新增适应症开展临床试验。NS-041片是一款新型高选择性KCNQ2/3激动剂，目标用于癫痫和抑郁症等神经精神类疾病的治疗，系目前国内唯一获批同时开展癫痫和抑郁症临床研究的KCNQ2/3靶向药物。2023年12月27日，NS-041片获批开展“癫痫”适应症的临床试验，目前该适应症正在进行II期临床研究。本次NS-041片新增获批的临床试验适应症为“治疗抑郁症”。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2593260501","isCrawlerRequest":true}